David Adam Gass MD
Pediatric Neuro-Oncology
Assistant Professor
Join to View Full Profile
1001 Blythe BlvdMedical Center Plaza, Suite 601Charlotte, NC 28203
Phone+1 704-381-9900
Fax+1 704-381-9901
Dr. Gass is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2013 - 2014
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2010 - 2013
NYU Grossman School of MedicineResidency, Pediatrics, 2007 - 2010
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2007
Certifications & Licensure
NC State Medical License 2014 - 2025
NY State Medical License 2008 - 2015
OH State Medical License 2013 - 2014
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 10 citationsClinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.Ayse Bahar Ercan, Melyssa Aronson, Nicholas R Fernandez, Yuan Chang, Adrian Levine
The Lancet. Oncology. 2024-05-01 - 8 citationsCombined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Con...Anirban Das, Nicholas R Fernandez, Adrian Levine, Vanessa Bianchi, Lucie K Stengs
Cancer Discovery. 2024-02-08 - 7 citationsPhase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report.Mariko DeWire, Margot Lazow, Olivia Campagne, James Leach, Christine Fuller
Neuro-Oncology Advances. 2022-04-16
Press Mentions
- Use of a Response-Adapted Ruxolitinib-Containing Regimen for the Treatment of Hemophagocytic LymphohistiocytosisSeptember 16th, 2020
Halifax Medical School Urging Students to Become Family Doctors to Ease ShortageAugust 13th, 2019- Use of a Response-Adapted Ruxolitinib-Containing Regimen for the Treatment of Hemophagocytic LymphohistiocytosisJuly 27th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
